Publications

Publications

Filter Results: (130) Arrow Down

Show Results For

← Page 5 of 130 Results →

    Larissa Bifano

    Larissa Bifano concentrates on patent and other intellectual property strategy, counseling, prosecution, diligence, and litigation in the United States Patent and Trademark... View Details
    Keywords: Legal
    • Web

    Law, Management and Entrepreneurship - Course Catalog

    school should enroll in LME Career Focus: Every MBA should understand how law affects business. In addition to serving as a Senior Lecturer at HBS, I am a retired Securities Litigation Partner at WilmerHale in Boston. I draw upon examples... View Details
    • 26 Sep 2017
    • First Look

    First Look at New Research and Ideas, September 26, 2017

    data for themselves and look forward to the new questions they can tackle with it. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53265 forthcoming Boston University Law Review Troll Check? A Proposal for Administrative Review of View Details
    Keywords: Sean Silverthorne
    • 30 Dec 2013
    • Research & Ideas

    Most Popular Articles of 2013

    Lemmens and Sunil Gupta provides a novel method for determining which customers to target in order to maximize the profit of a retention campaign. The Impact of Patent Wars on Firm Strategy: Evidence from the Global Smartphone Market... View Details
    Keywords: by Staff
    • 11 Dec 2007
    • First Look

    First Look: December 11, 2007

    Patents as Real Options: Value and Disclosure as Drivers of Litigation Authors:Atul Nerkar, Srikanth Paruchuri and Mukti Khaire Periodical:In Real Options Theory. Vol. 24, edited by Jeffrey J. Reuer and Tony... View Details
    Keywords: Martha Lagace
    • 01 Mar 2007
    • News

    Daniel Vasella

    the Democrats are probably unhappy that the Republicans passed the prescription drug law. And some don’t like the fact that it relied on private insurance providers. Do drug companies have sufficient patent protection for new products?... View Details
    Keywords: Roger Thompson; multinational pharmaceutical company; prescription drugs; vaccines; Medicare; generics business; Health, Social Assistance
    • 30 Oct 2012
    • First Look

    First Look: October 30

    salary allocations to online ad clicks to admission decisions.   Working PapersSecurities Litigation Risk for Foreign Companies Listed in the U.S. Authors:Beiting Cheng, Suraj Srinivasan, and Gwen Yu Abstract We study securities View Details
    Keywords: Sean Silverthorne
    • 29 Sep 2011
    • Sharpening Your Skills

    Sharpening Your Skills: Leveraging Intellectual Property

    a cure-all, but rather as a tool with both strengths and weaknesses. The increasing use of patent pools to share technology is one method for firms to avoid costly litigation arising from overlapping View Details
    Keywords: Re: Multiple Faculty
    • 13 Sep 2016
    • First Look

    September 13, 2016

    enjoyment. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51423 Patent Trolls: Evidence from Targeted Firms By: Cohen, Lauren, Umit G. Gurun, and Scott Duke Kominers Abstract—We develop a theoretical model of, and... View Details
    • 14 Jun 2016
    • First Look

    June 14, 2016

    Behavior and Impact of Patent Trolls: A Survey By: Cohen, Lauren, Umit Gurun, and Scott Duke Kominers Abstract—We survey the empirical literature on non-practicing entity (NPE) litigation behavior and its... View Details
    Keywords: Sean Silverthorne
    • 11 Oct 2016
    • First Look

    October 11, 2016

    litigation strategically respond to increased litigation risks in this industry. We find that as patent wars intensify, smartphone vendors not involved in any View Details
    Keywords: Sean Silverthorne
    • 01 Sep 2004
    • News

    Books

    Innovation and Its Discontents by Josh Lerner and Adam B. Jaffe (Princeton University Press) Innovation and Its Discontents tells the story of how recent changes in patenting — an institutional process that was created to nurture... View Details
    Keywords: Colleges, Universities, and Professional Schools; Educational Services
    • 24 Jun 2014
    • First Look

    First Look: June 24

    to curb the monopoly power that they create, most standard-setting organizations require the owners of patents covered by the standard to make a loose commitment to grant licenses on reasonable terms. Such commitments unsurprisingly are... View Details
    Keywords: Sean Silverthorne
    • July 2008 (Revised September 2008)
    • Case

    Recent Developments in the Ranbaxy Case

    By: Robert C. Pozen
    This brief case describes settlements Indian drug maker Ranbaxy has made with Pfizer and AstraZeneca, as well as Daiichi Kangyo's purchase of a majority shareholding in Ranbaxy in 2008. View Details
    Keywords: Mergers and Acquisitions; Patents; Lawsuits and Litigation; Ownership Stake; Pharmaceutical Industry; India
    Related
    • 28 Jul 2015
    • First Look

    First Look: July 28, 2015

    NPEs appear to behave as opportunistic patent trolls. NPEs sue cash-rich firms-a one standard deviation increase in cash holdings increases a firm's chance of being targeted by NPE litigation more than... View Details
    Keywords: Carmen Nobel
    • April 2008 (Revised August 2008)
    • Supplement

    AT&T v. Microsoft (B): District Court Ruling and Appeal

    By: Willy C. Shih
    The (B) case follows the course of Microsoft's settlement with AT&T, and its appeal in the issue of foreign replicated software that eventually goes to the U.S. Supreme Court. It is intended for follow-up the discussion of the (A) case with what happened, examining a... View Details
    Keywords: Patents; Lawsuits and Litigation; Conflict and Resolution; Competitive Strategy; Technology Industry
    Related
    • September 2010
    • Teaching Note

    Alnylam Pharmaceuticals: Building Value from the IP Estate (TN)

    By: Willy C. Shih
    Teaching Note for 611009. View Details
    Keywords: Value; Patents; Corporate Strategy; Competition; Research and Development; Lawsuits and Litigation; Pharmaceutical Industry; United States
    Related
    • 11 Mar 2014
    • First Look

    First Look: March 11

    national stakeholders to initiate litigation against the focal firm. We test our predictions using a two-pronged empirical strategy. Our empirical context relates to herbal patents from emerging markets, and... View Details
    Keywords: Sean Silverthorne
    • 16 Sep 2008
    • First Look

    First Look: September 16, 2008

    Abstract This paper examines the litigation of patents relating to financial products and services. I show that these grants are being litigated at a rate 27 to 39 times... View Details
    • 22 Jul 2014
    • First Look

    First Look: July 22

    unrelated to the allegedly infringing patents. We next show that NPEs target firms irrespective of the closeness of those firms' patents to the NPEs', and that NPEs typically target firms that are busy with other (non-IP related) lawsuits... View Details
    Keywords: Sean Silverthorne